Erste Asset Management

22 results for keyword "Russia"

Article on tag "Russia"

Escalation of the conflict between Russia and Ukraine: are the markets at risk?
Escalation of the conflict between Russia and Ukraine: are the markets at risk?
(c) SAUL LOEB / AFP / picturedesk.com

Escalation of the conflict between Russia and Ukraine: are the markets at risk?

The Russia/Ukraine conflict is keeping the markets in suspense. Everything is possible – from continued diplomacy in order to contain the escalation to harder sanctions in case of a more comprehensive invasion. The volatility on the financial markets will remain high.

OPEC+ haggling over production restrictions at ongoing meeting
OPEC+ haggling over production restrictions at ongoing meeting
(c) unsplash

OPEC+ haggling over production restrictions at ongoing meeting

The eyes of the international business world are currently fixed on Vienna. At the OPEC headquarters in downtown Vienna, the oil cartel’s member states and its allies are currently haggling over production volumes, and thus the further development of oil prices, via video conference.

COVID-19 Update from the Investment Division: Russia to the Rescue?
COVID-19 Update from the Investment Division: Russia to the Rescue?
(c) unsplash

COVID-19 Update from the Investment Division: Russia to the Rescue?

Researchers from Moscow-based Gamaleya institute, an offshoot of the Russian Ministry of Health, published detailed phase 1/2 results of their COVID-19 vaccine in the Lancet. If true (remember that we are talking about Russia), these results imply that their vaccine is both effective and has a tolerable safety profile which would make it a strong contender in the international race to defeat COVID-19.

COVID19 Update: Sputnik V – the vaccine that came in from the cold
COVID19 Update: Sputnik V – the vaccine that came in from the cold
(c) unsplash

COVID19 Update: Sputnik V – the vaccine that came in from the cold

When Russian President Vladimir Putin celebrated his “Mission Accomplished” moment on August 11th with the announcement of Sputnik V, the world’s first SARS-CoV-2 vaccine, the global scientific community reacted with a mix of skepticism and condemnation. Is this warranted or a result of russophobia?